【FINTEC 0150 交流专区】（前名 ASIABIO）

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD(“ASIABIO” OR THE “COMPANY”) - CLARIFICATION ON THE NEWS ARTICLE TITLED “ASIABIO MOVES INTO O&G TRANSPORTATION” BY THE BUSINESS TIMES DATED 28 JANUARY 2015
ASIABIO refers to the news article titled “Asiabio moves into O&G transportation” by Business Times on 28 January 2015. ASIABIO, having made due and diligent enquiry with the Board of Directors of the Company, wishes to clarify that the consideration amount of RM168 million, mode of payment for the O&G transport firms, namely Semua Shipping Sdn Bhd (SSSB) and Semado Maritime Sdn Bhd (SMSB), and projected income as reported in the news article are quoted based on the Company’s preliminary indicative valuation and structuring proposal.  The consideration sum and the number of shares to be issued by the Company will nevertheless be subject to further revisions after performing further evaluation, due diligence and negotiation to be concluded between the parties, before culminating into a definitive agreement to be signed following the execution of the Heads of Agreement. As such, the information as provided in the article was not included in the Company’s announcement released on 27 January 2015. The Company will make the appropriate announcement to Bursa Malaysia Securities Berhad (“Bursa Securities”) in a timely manner in accordance with Bursa Securities’ Listing Requirements, should there be any further development on this matter. This announcement is dated 28 January 2015.

icy97

亞洲生物能源進軍油氣運輸業

2015-02-08 10:08      
（吉隆坡7日訊）虧損連連的亞洲生物能源（ASIABIO,0150,創業板貿服組），打算多元化至油氣運輸業。

亞洲生物能源1月30日公佈消息後，股價猛升29%至24.5仙，寫下2009年3月以來最高紀錄，過後卻在2月4日急挫近33%，跌至16.5仙。今年至今，其股價仍升高32%。

外界對於這家生物柴油公司能否順利開展油氣運輸業務，甚至扭轉虧損命運而疑慮四起。

該公司執行董事陳石義接受《The Edge》專訪時說，現在是收購油輪公司的良機，因為經營開銷降低了。

“低油價確實改變了許多事情。展望未來，Semua船運這類公司是不錯的投資對象，畢竟營運成本已經下降了。如果油價衝上100美元，我們就只能望門興嘆了。”

1月27日，該公司宣佈與和隆集團（HLCL）、幸馬泰資源（SUMATEC,1201,主板貿服組）和Reachmont物流有限公司（RLSB）簽署框架合約，優先洽購Semua船運和Semato海事。

根據協議，該公司將發行總值1億6千800萬令吉新股，或佔擴大後繳足資本的20%，用以收購上述資產。

過後，Semua船運和Semato海事的股權將轉到特別用途公司（SPV），而幸馬泰則將特別用途公司的49%股權轉給Reachmont，代價是Reachmont協助幸馬泰減少拖欠的5千600萬令吉債務。（星洲日報／財經‧The Edge專版）

icy97

执行董事减持成小股东 亚洲生化称不知异动原因

财经新闻 财经  2015-02-25 07:46
（吉隆坡24日讯）亚洲生化（ASIABIO，0150，创业板）表示，不知道导致股价异动的原因。

由于该公司近期交投异常热络，因此在今天遭马交所发出不寻常市场交易（UMA）质询。

亚洲生化在答复马交所时指出，该公司没有任何重大企业活动或传言，会导致股价异动，因此，不知道股价异动的原因。

农历新年假期结束后的首日交易，亚洲生化的成交量就比上个交易日大涨640%，达1亿2996万1200股。

针对交投异常热络，马交所今天通过文告，向亚洲生化发出UMA质询。

亚洲生化今天交投持续升温，全天共有2亿854万6600股易手，约占马股总成交量的10%，也成为全场最热门股项，闭市收在12.5仙，全天滑落1.5仙，或10.71%。

梁国强卖2070万股

不过，亚洲生化执行董事梁国强因脱售股权，加上其他股东行使凭单，导致他的股权降低至5%以下，不再是公司大股东。

根据彭博社数据，梁国强是透过Acritaz控股及Platimas私人有限公司，间接持有5.8%和1.3%股权，而本身则直接持有733股。

不过，Acritaz控股在今天脱售2070万股，每股售价13.5仙，而持股权也降低至4.7%，不再是大股东。

在1月底，亚洲生化宣布通过发行总值1.68亿令吉的股票，收购两家油气物流公司，借此进军油气下游业。【南洋网财经】

Notice of Person Ceasing (29C)

ASIA BIOENERGY TECHNOLOGIES BERHAD

Particulars of substantial Securities Holder

Name	Acritaz Holdings Sdn. Bhd.
Address	13A06 Lobby 1 Block A Damansara Intan 1 Jalan SS20/27 47400 Petaling Jaya Selangor
NRIC/Passport No/Company No.	736665-T
Nationality/Country of incorporation	Malaysia
Descriptions (Class & nominal value)	Ordinary Shares of RM0.10 each
Date of cessation	24/02/2015
Name & address of registered holder	Acritaz Holdings Sdn. Bhd. 13A06 Lobby 1 Block A Damansara Intan 1 Jalan SS20/27 47400 Petaling Jaya Selangor
Currency	Malaysian Ringgit (MYR)
Number of securities disposed	20,700,000
Price Transacted ($$)
Circumstances by reason of which a person ceases to be a substantial securities Holder	Disposal of shares and conversion of warrants by other shareholders
Nature of interest	Direct interest
Date of notice	24/02/2015

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” or “the Company”) - ACQUISITION OF SHARES IN NETX HOLDINGS BERHAD
Pursuant to Rule 9.19(26) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad (“ACE LR”), ASIABIO wishes to announce that Asiabio Capital Sdn. Bhd., a wholly-owned subsidiary of the Company, has since 9 October 2014 cumulatively acquired a total of 6.07% equity in Netx Holdings Berhad (“Netx”), a listed entity on the ACE Market of Bursa Malaysia Securities Berhad (“Investment in the Shares of Netx”). The acquired shares which amounted to 38,000,000 ordinary shares of par value RM0.10 each was acquired from the open market for a total cash consideration sum of RM2,670,000.00. None of the Directors and/or substantial shareholders and/or any person connected to the Directors and/or substantial shareholders of ASIABIO has any interest, either direct or indirect, in the acquisition of shares in Netx. The highest percentage ratio applicable to the Investment in the Shares of Netx pursuant to Rule 10.02(g) of the ACE LR is 4.11% based on the latest audited financial statements of ASIABIO as at 31 January 2014 and Netx, as at 30 June 2014. This announcement is dated 10 March 2015.

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR THE “COMPANY”) INVESTMENT AND TRADING OF VARIOUS QUOTED SECURITIES:- ACQUISITION:- • FOCUS DYNAMICS TECHNOLOGIES BERHAD DISPOSAL:- • CARIMIN PETROLEUM BERHAD
The Board of Directors of Asia Bioenergy Technologies Berhad (“ABT” or “the Company”) wishes to announce that its wholly owned subsidiary, Asiabio Capital Sdn Bhd (“ACSB”) that is principally involved in the trading of marketable securities has made acquisition and disposal of the following quoted securities:- Acquisition Focus Dynamics Technologies Berhad (“FOCUS”) Disposal Carimin Petroleum Berhad (“CARIMIN”) Please refer to the attachment for details of the Acquisition and Disposal. This announcement is dated 17 March 2015. http://www.bursamalaysia.com/market/listed-companies/company-announcements/1905825

Attachments ABT Ann Investment (Carimin and Focus) 17 March 2015 (final).pdf

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR THE “COMPANY”) - DISPOSAL OF SHARES IN GRAPHENE NANOCHEM PLC (“GN”)
1.            INTRODUCTION The Board of Directors of Asia Bioenergy Technologies Berhad (“ABT” or “the Company”) wishes to announce that its wholly owned subsidiary, Asiabio Capital Sdn Bhd (“ACSB”) that is principally involved in the trading of marketable securities has over the past twelve (12) months disposed off in aggregate 1,160,936 ordinary shares of in Graphene Nanochem Plc (“GN”) for an aggregated sum of RM3.74 million (“GN Consideration”) in cash and in exchange for 416.9409 units of the Bridge Global Growth Fund (“BGGF”) valued at USD416,940.90 or RM1.36 million based on the exchange rate of RM3.262:USD1.00 on 6 October 2014, being the date of the swap (hereinafter referred to as the “Divestment in GN / Investment in BGGF”). 2.         DETAILS OF THE DIVESTMENT IN GN / INVESTMENT IN BGGF 2.1       Information of GN GN is a public listed company listed on the AIM Market of London Stock Exchange. GN is a global nanotechnology company that designs, formulates, manufactures and markets a range of speciality chemicals and advanced materials. Based on the latest audited accounts of GN as at 31 December 2013, its net profit attributable to assets for the year ended and net assets are USD3.67 billion and USD45.89 billion respectively. 2.2       Information on BGGF BGGF is an unquoted fund managed by Bridge Global Absolute Return Fund (“BGARF”), a Segregated Portfolio Company based in the Cayman Islands, whose objective is to deliver an absolute return for investors using a multi-portfolio investment approach. 2.3       Basis of Arriving At the GN Consideration The GN Consideration was derived from the sale of the GN shares in the open market between 17 June 2014 and 2 October 2014 and the exchange of 387,933 GN shares for 416.9409 BGGF units based on the traded price of GN shares on 6 October 2014 of GBP0.6959 or RM3.51 based on the exchange rate of RM5.0438:GBP1.00 on 6 October 2014. 2.4       Utilisation of Proceeds The cash proceeds amounting to RM2.38 million from the Divestment in GN / Investment in BGGF will be channeled back to ABT’s technology incubator funds which will be used for future investments in a three (3) year timeframe. 2.5       Liabilities to be Assumed There are no liabilities, including contingent liabilities and guarantees to be assumed by ABT, arising from the Divestment in GN / Investment in BGGF. 2.6       Original Cost and Date of Investment Part of the GN shares disposed by ACSB was acquired upon the completion of the disposal of 1,143,434 ordinary shares of RM1.00 each in Platinum Nanochem Sdn Bhd (“PNSB”) (representing 1.56% of the equity interest in PNSB) by ABT to Biofutures International Plc (presently known as GN), which was announced by the Company on 26 March 2013, in exchange for 21,018,714 GN shares of 1 pence each that was later consolidated in 1,050,936 GN shares of 20 pence each. The original cost of investment for the PNSB shares held by ABT is RM0.19 million made on 30 June 2012.  The disposal of the PNSB shares for the GN shares resulted in ABT Group realizing a gain on disposal of RM4,463,446 for the financial year ended 31 January 2014. Subsequently further acquisitions of GN shares were made via the open market on 13 September 2014 and 25 September 2014 for a consideration amount of RM0.35 million. 3.         RATIONALE FOR THE DIVESTMENT IN GN / INVESTMENT IN BGGF The Divestment in GN / Investment in BGGF is part of ABT Group’s decision to recoup back its investments in GN, having held that investment since 2013 and reinvestment into the BGGF units that is being managed by BGARF. 4.         RISK FACTORS Save for the normal market and global economic risk, the Board of Directors of ABT is not aware of any other risk factors which may arise as a result of the Divestment in GN / Investment in BGGF. 5.         FINANCIAL EFFECTS The Divestment in GN / Investment in BGGF is not expected to have any material effect on the dividend policy, gearing, share capital and the substantial shareholders’ shareholdings of ABT for the financial year ended 31 January 2015. The Divestment in GN / Investment in BGGF is expected to result in ABT Group recording a loss of RM2.63 million based on the latest book value as adjusted for changes in fair value, for the financial year ended 31 January 2015, which translates to a decrease in earnings per share of approximately 0.003 sen. 6.         APPROVAL REQUIRED The Divestment in GN / Investment in BGGF is not subject to the approval of the shareholders of the Company or any regulatory authorities. 7.         DIRECTORS’ AND SUBSTANTIAL SHAREHOLDERS’ INTEREST None of the Directors and/or substantial shareholders and/or any person connected to the Directors and/or substantial shareholders of ABT has any interest, either direct or indirect in the Divestment in GN / Investment in BGGF. 8.         DIRECTORS’ STATEMENT The Board of Directors of ABT having considered all aspects of the Divestment in GN / Investment in BGGF is of the opinion that it is in the best interest of the ABT Group. 9.         PERCENTAGE RATIO The highest percentage ratio applicable to the Divestment in GN / Investment in BGGF pursuant to Rule 10.02 of the Listing Requirements of Bursa Malaysia Securities Berhad for the ACE Market is 5.76% based on the latest audited financial statements of ABT as at 31 January 2014, adjusting for the completed Rights Issue with Warrants of ABT on 28 April 2014 and GN as at 31 December 2013. This announcement is dated 17 March 2015.

icy97

Change of Financial Year End

ASIA BIOENERGY TECHNOLOGIES BERHAD

Old financial year end	31/01/2015
New financial year end	31/03/2015

Remarks :

The Board of Directors of Asia Bioenergy Technologies Berhad has approved the change of financial year end of the Company from 31 January to 31 March. Thus, the next set of audited financial statements will be made up from 1 February 2014 to 31 March 2015 covering a period of fourteen (14) months. Thereafter, the financial year end of the Company shall end on 31 March for each subsequent year.

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR “THE COMPANY”) - DISPOSAL OF SHARES IN GRAPHENE NANOCHEM PLC ("GN")
We refer to the Company’s announcement dated 17 March 2015. The Board of Directors of the Company wishes to clarify the following:- (i) The aggregated disposal sum of RM3.74 million is comprised of a cash proceed of RM2.38 million from the disposal of the GN shares in the open market and a swap for the 416.9409 units of the Bridge Global Growth Fund (“BGGF”) valued at USD416,940.90 or RM1.36 million based on the exchange rate of RM3.262:USD1.00 on 6 October 2014, being the date of the swap. (ii) The Divestment in GN / Investment in BGGF is expected to result in ABT Group recording a loss of RM2.63 million based on the latest book value as adjusted for changes in fair value, which translates to a decrease in earnings per share and net assets per share of approximately 0.003 sen for the financial year ended 31 January 2014, as well as for the financial period ending 31 March 2015, due to the change in the financial year end. This announcement is dated 18 March 2015.

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR THE “COMPANY”) INVESTMENT AND TRADING OF VARIOUS QUOTED SECURITIES:- ACQUISITION:- • FOCUS DYNAMICS TECHNOLOGIES BERHAD DISPOSAL:- • CARIMIN PETROLEUM BERHAD
We refer to the Company’s announcement dated 17 March 2015. The Board of Directors of the Company wishes to clarify the following:- (i) The Investment in FOCUS as defined, is not expected to have any material effect on earnings per share and net assets per share, for the financial year ended 31 January 2014, as well as for the financial period ending 31 March 2015, due to the change in the financial year end. (ii) The Divestment in CARIMIN as defined, is expected to result in ABT Group recording an additional loss of RM0.76 million equivalent to a decrease in earnings per share and net assets per share of approximately 0.09 sen, for the financial year ended 31 January 2014, as well as for the financial period ending 31 March 2015, due to the change in the financial year end. This announcement is dated 18 March 2015.

alanyeow

大户终于来了

Secret_agent91

又是相同的手段...
大家小心了～

Semua Shipping 2014 June还亏损RM3m++。 年头Asiabio宣布准备收购Semua Shipping以及Semado Maritime后，Semua shipping年尾的帐目净盈利RM8m.

Semua船運和Semato海事的股權將轉到特別用途公司（SPV），而幸馬泰則將特別用途公司的49%股權轉給Reachmont，代價是Reachmont協助幸馬泰減少拖欠的5千600萬令吉債務。（星洲日報／財經‧The Edge專版）

Reachmont的股东Bong Siet Fatt其实原本就是Semua的GM。

原因是Semua Shipping与Semado Maritime的持有大股东，也就是Hoe Leong Corporation在帐目上做了adjustment让Semua Shipping从亏损变成赚钱。

Hoe Leong Corporation 也是 Ebony Ritz Sdn Bhd 的大股东，持有80% Ebony Ritz。

Secret_agent91

Semua Shipping原本都是亏损的，大股东Hoe Leong Corporation就算损失SGD3.9m interest & admin fee都要卖掉Semua shipping，让Semua Shipping在大众眼里看来是赚钱的公司。

这一切Asiabio的director Steve Tan都已经是知道了的。如果Asiabio坚持收购，就像回之前的炒作。

大众的血汗钱，要小心了。鲨鱼出现～

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/01/2015

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/01/2015	31/01/2014	31/01/2015	31/01/2014
		$$'000	$$'000	$$'000	$$'000

1	Revenue	15,239	2,266	51,341	3,700
2	Profit/(loss) before tax	-5,048	267	-6,359	-709
3	Profit/(loss) for the period	-5,048	267	-6,359	-710
4	Profit/(loss) attributable to ordinary equity holders of the parent	-4,558	269	-6,230	-645
5	Basic earnings/(loss) per share (Subunit)	-0.43	0.07	-0.59	-0.16
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0709		0.0559

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) ESOS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR THE “COMPANY”) (I)        PROPOSED SHARE ISSUANCE SCHEME; AND (II)        PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL
On behalf of the Board of Directors of ABT, TA Securities Holdings Berhad wishes to announce that the Company proposes to undertake the Proposals. Please refer to the attachment for further details of the announcement. This announcement is dated 6 April 2015. http://www.bursamalaysia.com/market/listed-companies/company-announcements/1925129

Attachments ABT Announcement.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR THE “COMPANY”) - PROPOSED ACQUISITION OF COMPANY
The Board of Directors of ABT wishes to announce that the Company had on 9 April 2015 acquired the entire shares of Artisan Semesta Sdn Bhd (“ASSB”) for a total cash consideration of RM2.00 (“Acquisition”). ASSB was incorporated on 5 May 2011 pursuant to the Companies Act, 1965 as a private limited company and has been dormant since its incorporation. The authorised share capital of ASSB is RM100,000.00 divided into 100,000 ordinary shares of RM1.00 each and the paid-up capital is RM2.00 divided into 2 ordinary shares of RM1.00 each. The Acquisition would not have material effect on ABT Group’s earnings per share, net assets per share, gearing, share capital and substantial shareholders’ shareholding for the financial year ending 31 March 2016. Subsequent to the Acquisition, ASSB shall become a wholly-owned subsidiary of ABT. None of the Directors and/or major shareholders of the Company or persons connected with them have any interest, direct or indirect, in the Acquisition, save for Mr Looi Kem Loong, a Director of ABT, who also acts as a Director of ASSB and his spouse, Ms Loh Woan Fen, who is also a Director of ASSB. Having considered all aspects of the Acquisition, the Board of Directors of ABT is of the opinion that the Acquisition is in the best interest of ABT. This announcement is dated 9 April 2015.

icy97

icy97 发表于 18-3-2015 03:57 AM

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ASIABIO" OR "THE COMPANY")- Clarification on announcements pertaining to Disposal of shares in Graphene Nanochem PLC; Acquisition of shares in Netx Holdings Berhad; Investment and trading of various quoted securities
Further to the Company's announcements made on 17 March 2015, 10 March 2015 and 23 December 2014 pertaining to the (i) Disposal of Shares in Graphene Nanochem Plc., (ii) Acquisition of Shares in Netx Holdings Berhad and (iii) Investment and Trading of Various Quoted Securities respectively, the Board of Directors of AsiaBio wishes to make some clarifications to the aforesaid announcements. Please refer to the attachment for details of the above clarifications. This announcement is dated 8 May 2015.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/4731277

Attachments ABT - Announcement-Clarification on announcements.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2015

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		Two Months	Two Months	Fourteen Months	Fourteen Months
		01 Feb 2015 To	01 Feb 2014 To	01 Feb 2014 To	01 Feb 2013 To
		31 Mar 2015	31 Mar 2014	31 Mar 2015	31 Mar 2014
		$$'000	$$'000	$$'000	$$'000

1	Revenue	1,892	0	53,233	0
2	Profit/(loss) before tax	2,399	0	-3,960	0
3	Profit/(loss) for the period	2,399	0	-3,960	0
4	Profit/(loss) attributable to ordinary equity holders of the parent	2,456	0	-3,774	0
5	Basic earnings/(loss) per share (Subunit)	0.32	0.00	-0.50	0.00
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0742		0.0559

icy97

市场挑战严峻 亚洲生化今年攻出口

财经新闻 财经  2015-06-06 10:56
（吉隆坡5日讯）消费税和令吉疲弱令市场面临严峻挑战，亚洲生化（ASIABIO，0150，创业板）将着重于出口业务，支撑今年的业绩表现。

执行董事陈石义今天出席股东特大后指出，展望下半年，消费税落实导致市场充满挑战，但公司已部署多项计划带动业务增长。

该公司于今年收购两家油气物流公司，借此进军油气下游业务，尽管如今油价大跌，但他正面认为，这可借机探讨油气业的投资良机。

“若收到相关的建议书，我们将深入作出分析和评估。”

他指出，油气业仍然是我国主要核心领域，尽管面对油价浮动，但是市场需求仍会增加。

尽管令吉下跌会影响公司购买机械设备，但是，该公司有生产和出口环保木材至国外，美元强势升值有利于收入增长。

联营计划卖关子

陈石义指出，目前与国内投资公司的联营计划，还处于洽谈阶段，暂不宜透露详情。

亚洲生化近年的营业额波动极大，他解释说这主要是因为股票投资业务的波动，而投资政策与股东的长期回酬息息相关。

亚洲生化的股东在今天的特大，批准了所有的议案，即发售公司30%股权，以及把注册股本从15亿增加至50亿股。【南洋网财经】

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ASIABIO" or "the Company")- COLLABORATION & ALLIANCE AGREEMENT
1.         INTRODUCTION The Board of Directors of ASIABIO is pleased to announce that on 15 June 2015, Artisan Semesta Sdn. Bhd. (“ASSB”), a wholly-owned subsidiary of the Company entered into a Collaboration & Alliance Agreement (“C&A Agreement”) with Solar Interactive Sdn. Bhd. (Company No. 855449-U) (“SISB”) having its principal business address at 12.2, 12th Floor, Menara Lien Hoee, No. 8, Persiaran Tropicana, Tropicana Golf & Country Resort, 47410 Petaling Jaya, Selangor Darul Ehsan, to collaborate in the planting and intercropping of food crops utilising ASSB’s effective micro-organisms (“EM”) products at SISB’s photovoltaic energy generation sites (hereinafter referred to as “Parties”). 2.         DETAILS OF THE C&A AGREEMENT 2.1       Salient Terms of C&A Agreement ASSB wishes to enter into a strategic alliance and collaboration with SISB wherein ASSB and SISB shall collaborate in the planting and intercropping of food crops utilising ASSB’s EM products at SISB’s photovoltaic energy generation sites. The planting of the food crops will utilise, but not limited to, organic hydroponic planting technologies. These advanced organic hydroponic technologies will be jointly developed by ASSB and SISB. SISB via its existing (and future) photovoltaic energy generation project sites is able to make available food crop planting space within those sites and enable the Parties to jointly plant and produce viable food crops. ASSB via its production, manufacturing and supply of EM will be able to avail the Parties of EM products to enhance the growth and yields of the food crop production. The C&A Agreement serves as an understanding that Parties shall collaborate exclusively to develop the available space made available by SISB and to utilise ASSB’s EM products for the planting and production of the identified food crops. SISB agrees to collaborate with ASSB wherein SISB shall assist and make available to the Parties the available space within its photovoltaic energy generation project sites, and ASSB agrees to collaborate with SISB wherein ASSB shall assist and make available its EM products for the planting of this food crops planting project (“The Project”). 2.2       Information on ASSB ASSB was incorporated in Malaysia on 5 May 2011 under the Companies Act, 1965 as a private limited company and is principally engaged in the manufacturing and trading in agricultural and related products. ASSB has an authorised share capital of RM100,000.00 and issued and fully paid up share capital of RM2.00 comprising 2 ordinary shares of RM1.00 each. 2.3       Information on SISB SISB was incorporated in Malaysia on 30 April 2009 under the Companies Act, 1965 as a private limited company and is principally engaged in photovoltaic energy generation project. SISB has an authorised share capital of RM500,000 and issued and fully paid up share capital of RM500,000 comprising 500,000 ordinary shares of RM1.00 each. The Shareholder of SISB is VSolar Group Berhad (100%) and the Directors are Ameezan Bin Jamal and Chieng Siong Kuong. 2.4       Term, Funding and Termination The Project costs and detailed investment terms of each available site shall be determined on a case to case basis mutually between the Parties. The term of the C&A Agreement is for a period of three (3) years, commencing on the date of the C&A Agreement, unless otherwise mutually extended or terminated. Either party may terminate the C&A Agreement upon delivery of written notice at least ninety (90) days prior to such termination.  Each party shall bear its own costs resulting from or related to the termination. 3.         EFFECT OF THE C&A AGREEMENT The C&A Agreement is expected to contribute positively to ASIABIO Group’s prospects in the medium term. However, the signing of this C&A Agreement will not have any immediate effect on the earnings, net assets, share capital and shareholdings structure of ASIABIO. The Company does not foresee any exceptional risk other than the normal operational risk associated with the signing of this C&A Agreement. 4.         DIRECTORS’ AND MAJOR SHAREHOLDERS’ INTERESTS None of the Directors or major shareholders or persons connected to the Directors or Major Shareholders has any direct or indirect interest in the C&A Agreement. 5.         STATEMENTS BY DIRECTORS The Board of Directors of ASIABIO is of the opinion that the C&A Agreement is in the ordinary course of business and of the best interest of the Group. This announcement is dated 15 June 2015.

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ASIABIO" or "the Company")- COLLABORATION & ALLIANCE AGREEMENT
Reference is made to the Company's announcement dated 15 June 2015. The Board of Directors of ASIABIO wishes to further inform that pursuant to terms of the Collaboration & Alliance Agreement (“C&A Agreement”) entered into between Artisan Semesta Sdn. Bhd., a wholly-owned subsidiary of ASIABIO (“ASSB”) and Solar Interactive Sdn. Bhd., a wholly-owned subsidiary of VSolar Group Berhad (“SISB”) (hereinafter referred to as “Parties”), SISB will assist and make available to the Parties the available space within its photovoltaic energy generation project sites for ASSB to utilise its effective micro-organisms products for the planting and production of the identified food. Below are the existing photovoltaic energy generation project sites of SISB which have been identified for the proposed collaboration in relation to the C&A Agreement:- # Project sites address Size of the project sites 1 Lot 3 of Lot 312366, Mukim Sungai Raya, Daerah Kinta, Perak Darul Ridzuan 1.5 acres 2 Lot 4 of Lot 312366, Mukim Sungai Raya, Daerah Kinta, Perak Darul Ridzuan 1.5 acres This announcement is dated 16 June 2015.